Accepted Manuscript Real-world effectiveness of 8 weeks treatment with ledipasvir/sofosbuvir in chronic hepatitis C Peter Buggisch, Johannes Vermehren, Stefan Mauss, Rainer Günther, Eckart Schott, Anita Pathil, Klaus Boeker, Tim Zimmermann, Gerlinde Teuber, Heike- Pfeiffer Vornkahl, Karl-Georg Simon, Claus Niederau, Heiner Wedemeyer, Stefan Zeuzem PII: S0168-8278(17)32431-5 DOI: https://doi.org/10.1016/j.jhep.2017.11.009 Reference: JHEPAT 6750 To appear in: Journal of Hepatology Received Date: 5 January 2017 Revised Date: 2 November 2017 Accepted Date: 3 November 2017 Please cite this article as: Buggisch, P., Vermehren, J., Mauss, S., Günther, R., Schott, E., Pathil, A., Boeker, K., Zimmermann, T., Teuber, G., Vornkahl, H-P., Simon, K-G., Niederau, C., Wedemeyer, H., Zeuzem, S., Real-world effectiveness of 8 weeks treatment with ledipasvir/sofosbuvir in chronic hepatitis C, Journal of Hepatology (2017), doi: https://doi.org/10.1016/j.jhep.2017.11.009 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.